Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase NA 1

Status

Active not recruiting 3Recruiting 1

Sponsor Class

NIH 5OTHER 4

Study Type

Interventional 3Observational 1

Sponsor

Cancer Type

Gastrointestinal 3Tumor-Agnostic 1

Conditions

Rectal Neoplasms 2Neoplasms 1Colorectal Neoplasms 1

Interventions

pembrolizumab 589Cyclophosphamide 539Magnetic Resonance Spectroscopy 523Radiotherapy 506Specimen Handling 503Nivolumab 407Cisplatin 370Carboplatin 358Biopsy 304Blood Specimen Collection 295Radiosurgery 283Paclitaxel 274Surveys and Questionnaires 268Standard of Care 266Gemcitabine 265fludarabine 261Dexamethasone 258Drug Therapy 256venetoclax 246Bevacizumab 246Oxaliplatin 206Rituximab 195Capecitabine 194Radiation 189Fluorouracil 186Ipilimumab 184durvalumab 180Doxorubicin 175atezolizumab 172Etoposide 171

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
OTHER × Sigmoidoscopy × 1 year × Clear all
NCT04600180 2025-11-25

DEFENCE

University Medical Center Groningen

Active not recruiting
38 enrolled
Tumor-Agnostic

Neoplasms

NCT03955510 2025-10-28

AFT

Rush University Medical Center

Phase NA Active not recruiting
12 enrolled
Gastrointestinal

Colorectal Neoplasms

NCT05610163 2025-09-08

JANUS

Alliance for Clinical Trials in Oncology

Phase 2 Active not recruiting
783 enrolled
Gastrointestinal

Rectal Neoplasms

NCT06780787 2025-06-26

FOLFOX, Botensilimab, and Balstilimab for the Treatment of Localized Rectal Cancer Before Surgery

City of Hope Medical Center

Phase 2 Recruiting
26 enrolled
Gastrointestinal

Rectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡